Gyre Therapeutics (GYRE) Current Leases (2019 - 2025)
Historic Current Leases for Gyre Therapeutics (GYRE) over the last 7 years, with Q3 2025 value amounting to $626000.0.
- Gyre Therapeutics' Current Leases fell 979.83% to $626000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $626000.0, marking a year-over-year decrease of 979.83%. This contributed to the annual value of $713000.0 for FY2024, which is 23952.38% up from last year.
- According to the latest figures from Q3 2025, Gyre Therapeutics' Current Leases is $626000.0, which was down 979.83% from $622000.0 recorded in Q2 2025.
- In the past 5 years, Gyre Therapeutics' Current Leases ranged from a high of $2.0 million in Q4 2021 and a low of $100000.0 during Q1 2024
- In the last 5 years, Gyre Therapeutics' Current Leases had a median value of $686000.0 in 2021 and averaged $933687.5.
- Its Current Leases has fluctuated over the past 5 years, first tumbled by 7933.84% in 2022, then soared by 70500.0% in 2025.
- Over the past 5 years, Gyre Therapeutics' Current Leases (Quarter) stood at $2.0 million in 2021, then tumbled by 75.11% to $492000.0 in 2022, then tumbled by 57.32% to $210000.0 in 2023, then skyrocketed by 239.52% to $713000.0 in 2024, then dropped by 12.2% to $626000.0 in 2025.
- Its Current Leases stands at $626000.0 for Q3 2025, versus $622000.0 for Q2 2025 and $805000.0 for Q1 2025.